Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells. 2015

Hui Xiong, and Ying Xu, and Guozhen Tan, and Yanfang Han, and Zengqi Tang, and Wenying Xu, and Fanqin Zeng, and Qing Guo
Department of Dermatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.

OBJECTIVE Glycyrrhizin (GL) is an important derivative of certain herbal medicines used in Asian countries. Currently, GL is used to treat hepatitis and allergic disease worldwide because of its anti-viral and anti-allergy effects. In addition to these prominent functions, GL likely regulates cellular functions such as tumor cell growth and cellular immunity. However, how GL affects the keratinocyte inflammation response remains poorly understood. The current paper investigates the effect of GL on psoriasis and explores the mechanisms involved. METHODS We used an in vitro cell model of tumor necrosis factor (TNF)-α-induced keratinocyte inflammation and the topical application of imiquimod (IMQ) using an animal model (mouse skin) of IMQ-induced psoriasis-like inflammation (IPI) to investigate the effect of GL on skin inflammation. Cell viability was analyzed using the Cell Counting Kit-8 (CCK8). Carboxyfluorescein succinimidyl ester (CFSE) labeling was used to trace monocyte adherence to keratinocytes. A Western blot analysis was used to detect the expression of intercellular adhesion molecule 1 (ICAM-1) and the activation of the nuclear factor (NF)-κB/mitogen-activated protein kinase (MAPK) signaling pathway. A modified version of the Psoriasis Area Severity Index (PASI) was used to monitor disease severity. Hematoxylin and eosin (H&E) staining was used to observe pathological changes. An immunohistochemistry (IHC) analysis was used to detect ICAM-1 expression in mouse skin. RESULTS GL treatment significantly reduced the levels of ICAM-1 in TNF-α-stimulated HaCaT cells, inhibited subsequent monocyte adhesion to keratinocytes, and suppressed the nuclear translation and phosphorylation of p65 following the degradation of inhibitor κB (IκB). GL treatment blocked the phosphorylation of extracellular signal-regulated kinase (ERK)/p38 MAPK. GL effectively delayed the onset of IPI in mice and ameliorated ongoing IPI, thereby reducing ICAM-1 expression in epidermal tissues. CONCLUSIONS These results demonstrate that GL treatment ameliorates skin inflammation by inhibiting ICAM-1 expression via interference with the ERK/p38 MAPK and NF-κB signaling pathways in keratinocytes. Therefore, GL can be used as an anti-psoriasis drug.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Hui Xiong, and Ying Xu, and Guozhen Tan, and Yanfang Han, and Zengqi Tang, and Wenying Xu, and Fanqin Zeng, and Qing Guo
April 2023, Immunopharmacology and immunotoxicology,
Hui Xiong, and Ying Xu, and Guozhen Tan, and Yanfang Han, and Zengqi Tang, and Wenying Xu, and Fanqin Zeng, and Qing Guo
June 2011, Biochemical and biophysical research communications,
Hui Xiong, and Ying Xu, and Guozhen Tan, and Yanfang Han, and Zengqi Tang, and Wenying Xu, and Fanqin Zeng, and Qing Guo
July 2017, International immunopharmacology,
Hui Xiong, and Ying Xu, and Guozhen Tan, and Yanfang Han, and Zengqi Tang, and Wenying Xu, and Fanqin Zeng, and Qing Guo
July 2021, International immunopharmacology,
Hui Xiong, and Ying Xu, and Guozhen Tan, and Yanfang Han, and Zengqi Tang, and Wenying Xu, and Fanqin Zeng, and Qing Guo
March 2016, International immunopharmacology,
Hui Xiong, and Ying Xu, and Guozhen Tan, and Yanfang Han, and Zengqi Tang, and Wenying Xu, and Fanqin Zeng, and Qing Guo
July 2015, International immunopharmacology,
Hui Xiong, and Ying Xu, and Guozhen Tan, and Yanfang Han, and Zengqi Tang, and Wenying Xu, and Fanqin Zeng, and Qing Guo
January 2020, Biochemical and biophysical research communications,
Hui Xiong, and Ying Xu, and Guozhen Tan, and Yanfang Han, and Zengqi Tang, and Wenying Xu, and Fanqin Zeng, and Qing Guo
November 2019, Journal of food biochemistry,
Hui Xiong, and Ying Xu, and Guozhen Tan, and Yanfang Han, and Zengqi Tang, and Wenying Xu, and Fanqin Zeng, and Qing Guo
February 2024, Current medical science,
Hui Xiong, and Ying Xu, and Guozhen Tan, and Yanfang Han, and Zengqi Tang, and Wenying Xu, and Fanqin Zeng, and Qing Guo
May 2017, International journal of molecular medicine,
Copied contents to your clipboard!